SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-18-000666
Filing Date
2018-02-14
Accepted
2018-02-14 17:29:20
Documents
3
Period of Report
2018-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_021418.htm 8-K 31636
2 PRESS RELEASE ex99-1.htm EX-99.1 10184
3 GRAPHIC ex99-1_img001.jpg GRAPHIC 12987
  Complete submission text file 0001387131-18-000666.txt   55777
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 18613930
SIC: 2834 Pharmaceutical Preparations